<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(2)</volume><submitter>Weisinger J</submitter><pubmed_abstract>&lt;h4>Objective&lt;/h4>The association of immune-mediated thrombotic thrombocytopenic purpura (iTTP) and SLE was previously described, but patients with iTTP with coexistent SLE remain poorly characterised.&lt;h4>Methods&lt;/h4>We compared the clinical presentation and the outcome of patients with iTTP with coexistent SLE (SLE-iTTP) to an age-sex matched cohort of patients with idiopathic iTTP without SLE.&lt;h4>Results&lt;/h4>During the study period, 1409 patients with iTTP were recruited in our registry. Of these, 79 (6%) had a prior or concurrent diagnosis of SLE at the time of iTTP diagnosis, and 437 (31%) had detectable ANAs without other clinical features of SLE. When compared with idiopathic iTTP, patients with SLE-iTTP had more severe renal involvement, and cardiac involvement was more prevalent, w</pubmed_abstract><journal>Lupus science &amp; medicine</journal><pagination>e001691</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12306328</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome.</pubmed_title><pmcid>PMC12306328</pmcid><pubmed_authors>Choukroun G</pubmed_authors><pubmed_authors>Poullin P</pubmed_authors><pubmed_authors>Weisinger J</pubmed_authors><pubmed_authors>Veyradier A</pubmed_authors><pubmed_authors>Bouzid R</pubmed_authors><pubmed_authors>Fadlallah J</pubmed_authors><pubmed_authors>Dana R</pubmed_authors><pubmed_authors>Delmas Y</pubmed_authors><pubmed_authors>Provot F</pubmed_authors><pubmed_authors>Rieu V</pubmed_authors><pubmed_authors>Coppo P</pubmed_authors><pubmed_authors>Benhamou Y</pubmed_authors><pubmed_authors>Marie M</pubmed_authors><pubmed_authors>Le Guern V</pubmed_authors><pubmed_authors>Chantepie S</pubmed_authors><pubmed_authors>Ribes D</pubmed_authors><pubmed_authors>Martis N</pubmed_authors><pubmed_authors>Joly BS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcome.</name><description>&lt;h4>Objective&lt;/h4>The association of immune-mediated thrombotic thrombocytopenic purpura (iTTP) and SLE was previously described, but patients with iTTP with coexistent SLE remain poorly characterised.&lt;h4>Methods&lt;/h4>We compared the clinical presentation and the outcome of patients with iTTP with coexistent SLE (SLE-iTTP) to an age-sex matched cohort of patients with idiopathic iTTP without SLE.&lt;h4>Results&lt;/h4>During the study period, 1409 patients with iTTP were recruited in our registry. Of these, 79 (6%) had a prior or concurrent diagnosis of SLE at the time of iTTP diagnosis, and 437 (31%) had detectable ANAs without other clinical features of SLE. When compared with idiopathic iTTP, patients with SLE-iTTP had more severe renal involvement, and cardiac involvement was more prevalent, w</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-03-31T11:03:52.602Z</modification><creation>2025-08-27T03:11:12.579Z</creation></dates><accession>S-EPMC12306328</accession><cross_references><pubmed>40730415</pubmed><doi>10.1136/lupus-2025-001691</doi></cross_references></HashMap>